Replies to post #2863 on Chelsea Therapeutics Intl Ltd fka CHIP

[kookiekook]

As part of meeting our commercialization needs, we plan to contract with a contract sales organization, or CSO, to provide sales representatives, sales managers, sales operations and back office services. In addition, we plan to hire or enter into contracts for additional manufacturing, scientific, regulatory, sales, marketing, finance, administration and operations staff. We also intend to continue using clinical research organizations and third parties to perform much of our clinical studies and manufacturing.

(pg 4 of the annual report)

This indicates to me that management has spent all their efforts on a possible buyout or merger, and have failed to plan for launching Northera. This may put Chelsea in a position where they need accept a lower buyout price than wanted or face a delayed launch for Northera with higher than normal expenses.